2-(Sec-butyl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one, 97%, 500g

Ethyl 8-oxo-8-(3-thienyl)octanoate, 97.0%, 1g

4,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,1,3-benzothiadiazole>95.0%(GC)5g

Lead(II) acetate hydrate 99.999% 50 g

2-(4-Methoxy-phenyl)-5-methyl-2H-pyrazol-3-ylamine, 95.0%, 1g

METHYL 3-OXO-1-METHYL-CYCLOBUTANECARBOXYLATE, 95.0%, 100g

2-(5-Bromopyridin-3-yl)-1,3,4-oxadiazole, 97%, 250mg

3-Bromo-4-(((tert-butoxycarbonyl)amino)methyl)benzoic acid, 98%, 100mg

ETHYL 5-OXOHEXANOATE, 95.0%, 5g

2-Bromothiazole-5-carboxylic Acid>97.0%(GC)(T)5g

Z-ILE-NH2, 97.0%, 100g

N-(2-(2-(2-Methoxy-4-MorpholinophenylaMino)-5-fluoropyriMidin-4-ylaMino)phenyl)MethanesulfonaMide, 98%, 250mg

Diisopropylamine, min 99.5%, for synthesis, 1L, glass packaging